Article
Resistance mutations in 23 S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center.
Journal of molecular biology - 19 Nov 1999
Kloss P, Xiong L, Shinabarger D L, Mankin A S
Abstract excerpt
Oxazolidinones represent a novel class of antibiotics that inhibit protein synthesis in sensitive bacteria. The mechanism of action and location of the binding site of these drugs is not clear. A new representative of oxazolidinone antibiotics, linezolid, was found to be active against bacteria and against the halophilic archaeon Halobacterium halobium. The use of H. halobium, which possess only one chromosomal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
